Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
about
Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a reviewThe evaluation and treatment of graves ophthalmopathyThe epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, MinnesotaIntervention in Graves' disease. Choosing among imperfect but effective treatment options.Thyroid-associated ophthalmopathy.Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.The evolving role of selenium in the treatment of graves' disease and ophthalmopathy.Relationship between management of hyperthyroidism and course of the ophthalmopathy.An overview of thyroid eye diseaseRecent developments in the medical treatment of thyroid eye disease.Endocrinology.Optic Neuropathy in Thyroid Eye Disease: A Case SeriesUpdate on thyroid eye disease and management.Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer.Graves' orbitopathy: imperfect treatments for a rare disease.The diagnosis and treatment of thyroid-associated ophthalmopathy.Medical management of thyroid eye disease.Diagnosis and management of Graves disease: a global overview.Total thyroid ablation in Graves' orbitopathy.Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis.Microsurgical endonasal decompression in dysthyroid orbitopathy.Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement.Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association.[Therapy with somatostatin analogs in patient with orbitopathy and positive Octreoscan]Total thyroidectomy is now the preferred option for the surgical management of Graves' disease.The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine.Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy.Thyroid eye disease: a Southeast Asian experience.Occurrence of Graves' Orbitopathy and Graves' Hyperthyroidism after a Trauma to the Eye.Management of Graves' disease in Australia.2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
P2860
Q26776335-267CD158-7C85-4F5C-A7FC-09B90746AEC5Q26862144-47929433-7F46-490F-8C75-0454EBC43CD5Q34164149-380B1EF1-58B3-4DEF-9A75-A70B832C5677Q35155022-524D20F1-5C88-4651-BE89-32212862BBBCQ35246094-927F3259-AF10-4DD1-B8AB-FC737E8088D0Q35592595-10BC07BE-2898-4997-8599-23C9EDD4E5C9Q35725329-895039A1-A875-4FC9-90B1-64DBC85B0C7CQ35785167-5C838243-6619-464B-882B-96FDC403D75CQ36305798-DE99003F-E758-4B00-A3C2-B12D91C5F0F8Q36497521-4B49C5C3-A9C3-4175-95F4-44B7B87A9DE8Q36681841-DC0FE276-F706-4EB9-8106-929737A0C5A5Q36963786-12D41B8F-5191-414B-BEE0-CA225134B21CQ37406589-E80AED1D-823B-4BBC-A28F-0303C15DC341Q37460205-083B4A7F-C5B9-4B24-94A3-791547CDE549Q37467757-A04815BA-0F7B-4529-A5A4-482314FDDAAAQ37582446-6EE3D1B5-F40C-4971-86C0-0BAD90254EE6Q37956160-1E898716-A2E2-41A8-A9AE-DDEEBE434C2EQ38130235-1A4AC895-CB54-4DF5-A6D2-CDAD59C4AAFBQ38152621-6C4DF9D0-CC43-4FAE-BA38-33D6477C5DD3Q38367695-C09E84D8-DBE2-4D79-8DAC-5688BA6F9811Q38843328-9C8C1924-44FF-4FDB-A39D-569A11F87CCEQ39432557-32CCD55E-EB72-4F41-9B2A-CF7779360C53Q41828250-486E7A7A-DA03-4981-A631-F6598DE05434Q43184328-02BC7CF9-EB82-4184-845D-9167299A3E4FQ43761597-27DB4A87-C2A3-4AFC-84D6-37588F3C0875Q44004575-E55E494E-3A9F-45B5-9A5D-EF58905FC872Q44402083-6C23364C-E2A2-4D3B-9327-39DC10A7E348Q48179202-D1764FEF-E7BC-45E1-BA3E-6F1AD803DAEEQ48818966-B7E68A3B-B33F-47AD-9B3A-CC2BE8C37C41Q52624186-8F6DC541-A691-4630-B98F-9484459C3292Q53330382-B6E30C46-761C-4641-B89E-94844998FB61Q57136607-2CFCAB25-1E7E-4008-82AE-56204B8CCAB0
P2860
Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Use of corticosteroids to prev ...... e therapy for hyperthyroidism.
@en
Use of corticosteroids to prev ...... e therapy for hyperthyroidism.
@nl
type
label
Use of corticosteroids to prev ...... e therapy for hyperthyroidism.
@en
Use of corticosteroids to prev ...... e therapy for hyperthyroidism.
@nl
prefLabel
Use of corticosteroids to prev ...... e therapy for hyperthyroidism.
@en
Use of corticosteroids to prev ...... e therapy for hyperthyroidism.
@nl
P2093
P1476
Use of corticosteroids to prev ...... e therapy for hyperthyroidism.
@en
P2093
P304
P356
10.1056/NEJM198911163212001
P407
P577
1989-11-01T00:00:00Z